Literature DB >> 15750469

Persistent parvovirus-associated chronic fatigue treated with high dose intravenous immunoglobulin.

Sean A McGhee1, Benjamin Kaska, Myron Liebhaber, E Richard Stiehm.   

Abstract

We report a 16-year-old boy with no evidence of immunodeficiency who had a 2-year history of chronic fatigue, low grade fever and slapped-cheek rash associated with chronic parvovirus B19 viremia. Prolonged intravenous immunoglobulin therapy resulted in resolution of his symptoms and viremia. Intravenous immunoglobulin may be useful in the resolution of parvovirus viremia regardless of immune status.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750469     DOI: 10.1097/01.inf.0000155194.66797.20

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

1.  Laryngitis and neutropenia from parvovirus-B19.

Authors:  Ozlem Yilmaz Ozbek; Ozge Surmeli Onay; Sibel Tulgar Kinik; Namik Ozbek
Journal:  Indian J Pediatr       Date:  2007-10       Impact factor: 1.967

Review 2.  Neurological aspects of human parvovirus B19 infection: a systematic review.

Authors:  Faraj Barah; Sigrid Whiteside; Sonia Batista; Julie Morris
Journal:  Rev Med Virol       Date:  2014-01-24       Impact factor: 6.989

Review 3.  Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.

Authors:  Jonas Blomberg; Carl-Gerhard Gottfries; Amal Elfaitouri; Muhammad Rizwan; Anders Rosén
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

Review 4.  Therapeutic use of immunoglobulins.

Authors:  E Richard Stiehm; Jordan S Orange; Mark Ballow; Heather Lehman
Journal:  Adv Pediatr       Date:  2010
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.